# Camden National Corp: overview

CAC · Nasdaq · CIK 750686 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cac.md) · [Financials](/companies/cac/financials.md) · [Filings](/companies/cac/filings.md) · [Insiders](/companies/cac/insiders.md)

Latest reported revenue: [$11.2m](/filings/0000750686-26-000062.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000750686-26-000062).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [9.1](/filings/0000750686-25-000306.md) | [9.4 d](/filings/0000750686-26-000010.md) | [9.5](/filings/0000750686-26-000026.md) | [10.4](/filings/0000750686-26-000062.md) | [10.6](/filings/0000750686-25-000306.md) | [11.3 d](/filings/0000750686-26-000010.md) | [9.7](/filings/0000750686-26-000026.md) | [11.2](/filings/0000750686-26-000062.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [144.0%](/filings/0000750686-25-000306.md) | [156.4% d](/filings/0000750686-26-000010.md) | [77.0%](/filings/0000750686-26-000026.md) | [135.9%](/filings/0000750686-26-000062.md) | [200.8%](/filings/0000750686-25-000306.md) | [199.5% d](/filings/0000750686-26-000010.md) | [224.9%](/filings/0000750686-26-000026.md) | [205.4%](/filings/0000750686-26-000062.md) |
| Diluted EPS | $ per share | [0.90](/filings/0000750686-25-000306.md) | not reported | [0.43](/filings/0000750686-26-000026.md) | [0.83](/filings/0000750686-26-000062.md) | [1.25](/filings/0000750686-25-000306.md) | not reported | [1.29](/filings/0000750686-26-000026.md) | [1.35](/filings/0000750686-26-000062.md) |
| Free cash flow | $m | [(16.2) d](/filings/0000750686-25-000306.md) | [41.2 d](/filings/0000750686-26-000010.md) | [(0.7)](/filings/0000750686-26-000026.md) | [4.5 d](/filings/0000750686-26-000062.md) | [35.4 d](/filings/0000750686-25-000306.md) | [19.0 d](/filings/0000750686-26-000010.md) | [18.2](/filings/0000750686-26-000026.md) | [29.9 d](/filings/0000750686-26-000062.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [32.0](/filings/0000750686-24-000025.md) | [33.3](/filings/0000750686-25-000044.md) | [33.6](/filings/0000750686-26-000010.md) | [35.7](/filings/0000750686-26-000010.md) | [41.7](/filings/0000750686-26-000010.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [216.0%](/filings/0000750686-24-000025.md) | [184.6%](/filings/0000750686-25-000044.md) | [129.2%](/filings/0000750686-26-000010.md) | [148.5%](/filings/0000750686-26-000010.md) | [156.1%](/filings/0000750686-26-000010.md) |
| Diluted EPS | $ per share | [4.60](/filings/0000750686-24-000025.md) | [4.17](/filings/0000750686-25-000044.md) | [2.97](/filings/0000750686-26-000010.md) | [3.62](/filings/0000750686-26-000010.md) | [3.84](/filings/0000750686-26-000010.md) |
| Free cash flow | $m | [141](/filings/0000750686-24-000025.md) | [103](/filings/0000750686-25-000044.md) | [64.9](/filings/0000750686-26-000010.md) | [55.4](/filings/0000750686-26-000010.md) | [58.2](/filings/0000750686-26-000010.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cac/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $96.7m | 1,782,726 |  | Added +192,610 |
| [FRANKLIN RESOURCES INC](/funds/38777.md) | 2026-06-30 | $85.5m | 1,577,173 |  | Added +11,352 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $72.1m | 1,330,677 |  | Reduced −77,094 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $46.7m | 862,045 |  | Added +31,695 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $40.9m | 753,784 |  | Reduced −8,909 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $32.0m | 590,172 |  | Added +77,424 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $24.4m | 449,219 |  | Added +20,947 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $20.7m | 382,362 |  | Added +156,765 |
| [BASSWOOD CAPITAL MANAGEMENT, L.L.C.](/funds/1085393.md) | 2026-06-30 | $13.4m | 247,699 |  | Unchanged |
| [MANUFACTURERS LIFE INSURANCE COMPANY, THE](/funds/928047.md) | 2026-06-30 | $12.7m | 234,102 |  | Reduced −1,667 |

## Recent filings

[All 1,698 filings](/companies/cac/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 08:05 ET | [8-K](/filings/0000750686-26-000071.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000750686-26-000071 |
| 2026-09-29 | 16:04 ET | [8-K](/filings/0000750686-26-000066.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000750686-26-000066 |
| 2026-08-06 | 10:13 ET | [10-Q](/filings/0000750686-26-000062.md) | Quarterly report, period 2026-06-30 | 0000750686-26-000062 |
| 2026-07-28 | 08:05 ET | [8-K](/filings/0000750686-26-000058.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000750686-26-000058 |
| 2026-07-06 | 16:05 ET | [8-K](/filings/0000750686-26-000053.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000750686-26-000053 |
| 2026-06-30 | 16:05 ET | [8-K](/filings/0000750686-26-000048.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000750686-26-000048 |
| 2026-06-18 | 08:05 ET | [8-K](/filings/0000750686-26-000036.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000750686-26-000036 |
| 2026-05-21 | 08:45 ET | [8-K](/filings/0000750686-26-000033.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000750686-26-000033 |
| 2026-05-11 | 16:06 ET | [8-K](/filings/0000750686-26-000031.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000750686-26-000031 |
| 2026-05-07 | 10:24 ET | [10-Q](/filings/0000750686-26-000026.md) | Quarterly report, period 2026-03-31 | 0000750686-26-000026 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000750686-26-000010.md), filed Mar 6, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/968b8607-9d2d-4980-a786-830e06187206)

## About the filer

- CIK: 750686
- Tickers: CAC
- Exchange: Nasdaq
- SIC code: 6021 National Commercial Banks
- State of incorporation: ME
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 11:28 ET. No prices; not investment advice.